Connect with us


‘Data analytics isn’t all about building magic models’

Voice Of EU



Data analytics researcher María Isabel Meza Silva is helping Irish manufacturing businesses step into the era of industry 4.0, and hopes to see the industry in Colombia follow suit.

Originally from Colombia, María Isabel Meza Silva holds a bachelor’s degree in industrial engineering from University of Los Andes. In 2017, she came to Ireland and joined Irish Manufacturing Research (IMR) as a data analytics intern.

IMR is an Enterprise Ireland and IDA-supported research and technology centre with labs and industrial pilot lines in Dublin and Mullingar. Following a few months back at University of Los Andes, Meza Silva returned to Ireland in 2018 and has been working as a fully fledged data analytics researcher at IMR since then.

Her main role is to help small and medium manufacturing businesses discover the value in their data. She does this by identifying key metrics and transforming raw data into meaningful and actionable insights.

Meza Silva also leads IMR’s outreach programmes with primary and secondary schools, immersing young students in new technologies such as the internet of things, AI, augmented reality and collaborative robots.

‘A common misconception is that analytics only works in large organisations with large resources’

What inspired you to become a researcher?

To be honest, it was not part of my plan to become a researcher when I was in university and I knew very little about what working as a researcher entailed. All I knew back then is that I wanted to work in manufacturing and have an impact in society. Since my dad brought me to the place where my favourite cereal was produced, I have always enjoyed going to factories and figured out how things are made and how machines work.

When I joined IMR as an intern, I realised the importance of applied research. IMR’s research is focused on using new technologies to help small and medium Irish companies improve their industrial processes. And if we can make these processes better for companies, why wouldn’t we? At the end of the day, manufacturing companies are the ones that provide us with the food we eat, the phones we use or the clothes we wear.

What research are you currently working on?

Some of the research projects we are currently working on were born as part of the Industrial Data Analytics Framework (IDAF) research project. During this project we realised that the main barriers to the adoption of analytics are generally managerial in nature and they probably stem from the lack of understanding around where to start and how to manage an analytics project, which also translates into a lack of understanding on how to go about solving problems using data science and inherent analytics capabilities.

In order to tackle this, the analytics team developed an industrial data analytics framework that aims to abstract the process that IMR has done with many companies, to produce a knowledge base that could be used as a self-service or guided tool for companies. This would provide an assessment of current analytics capability; a review of projects and techniques that are relevant for the present capability, infrastructure or culture; and the incremental steps that could be taken to bring value through new data analysis capabilities.

Based on the assessment, we have worked with companies to implement analytics initiatives that can bring value according to their current capabilities, and have established steps to increase their analytics capabilities. Understanding the current capabilities and process is key for companies to unlock the value in their data.

In your opinion, why is your research important?

As I mentioned, manufacturing companies are essential for the functioning of society. Think about the impact they have had during the Covid-19 pandemic. Several manufacturing companies repurposed their lines to start producing personal protective equipment while pharmaceutical companies are working non-stop to supply vaccines.

However, some of the processes that are used in manufacturing have not changed in decades because there has not been any need, and the fourth industrial revolution has brought advances that industry cannot ignore.

IMR aims to demystify, de-risk and deliver these emerging technologies that represent an opportunity for companies to make their industrial processes work better. Within the analytics team we work closely with industry to show them how data can be best used to increase revenue, customer satisfaction and product quality, and to make informed decisions.

What commercial applications do you foresee for your research?

Support Silicon Republic

There are three areas that companies have shown particular interest in when it comes to using data: predictive maintenance, defect analysis and overall equipment efficiency.

Predictive maintenance allows companies to decrease costs by foreseeing when a machine will fail and take actions before it happens, while defect analysis is being used to increase product quality by understanding the root cause of defects.

We have to work closely with industry in these areas to understand their business and concerns and we have developed and transferred technologies and applications to SMEs and multinational companies that can be potentially scaled up to manufacturing companies in Ireland and internationally.

What are some of the biggest challenges you face as a data analytics researcher?

I would say the main challenge is getting industry to see the importance or effectiveness of our research. In general, research is only effective when it is applied to processes that are changed considerably enough to have an impact. When it comes to analytics, most of our projects are based on data that companies may neither have nor use. Thus, getting the right data and showing the value in it is the first step, and the most important one, to get companies involved.

It is like trying to convince someone to change their habits knowing that they have always worked. The only way to do so it is by showing them with numbers and facts that there is always room for improvement.

Are there any common misconceptions about data analytics research?

The most common misconception about data analytics is that it is all about building ‘magic’ models. In fact, building a model is a single layer within the multiple phases that comprise a data analytics project.

For instance, delivering an analytics project includes data collection, data cleansing, verification of the data, data visualisation, exploratory data analysis, etc. At the end, all these steps can take up to 90pc of the time invested in the project with the other 10pc in developing the model.

Another common misconception is that analytics only works in large organisations with large resources. Analytics projects do not require sophisticated infrastructure to process and get the most value out of the data. In contrast, what matters is how data is used and interpreted to extract valuable information that will benefit business practices. This and the belief that access to large volume of data produces better and more accurate results often become barriers when engaging with small and medium enterprises. The best way to address these myths is by showing companies what they are capable of with the resources they have.

What are some of the areas of research you’d like to see tackled in the years ahead?

I would like to see where the concept of smart manufacturing will head. Will industry 4.0 and the technologies developed in it be embraced by the manufacturing sector? I think that is a question that will take a long time to answer, especially if we consider the technological differences and acceptance rate between the countries. I believe the adoption process is something industry and academia have to closely work together on if we want to make the most of it.

And, personally, now that I have seen the impact it can have, I would love to see some of the technologies adopted by Irish industry – such as collaborative robots, augmented reality or artificial intelligence – being implemented in Colombia.

Want stories like this and more direct to your inbox? Sign up for Tech Trends, Silicon Republic’s weekly digest of need-to-know tech news.

Are you a researcher with an interesting project to share? Let us know by emailing with the subject line ‘Science Uncovered’.

Source link


Ubiquiti dev charged with data-breaching own employer • The Register

Voice Of EU



A Ubiquiti developer has been charged with stealing data from the company and extortion attempts totalling $2m in what prosecutors claim was a vicious campaign to harm the firm’s share price – including allegedly planting fake press stories about the breaches.

US federal prosecutors claimed that 36-year-old Nickolas Sharp had used his “access as a trusted insider” to steal data from his employer’s AWS and GitHub instances before “posing as an anonymous hacker” to send a ransom demand of 50 Bitcoins.

The DoJ statement does not mention Sharp’s employer by name, but a Linkedin account in Sharp’s name says he worked for Ubiquiti as a cloud lead between August 2018 and March 2021, having previously worked for Amazon as a software development engineer.

In an eyebrow-raising indictment [PDF, 19 pages, non-searchable] prosecutors claim Sharp not only pwned his employer’s business from the inside but joined internal damage control efforts, and allegedly posed as a concerned whistleblower to make false claims about the company wrongly downplaying the attack’s severity, wiping $4bn off its market capitalisation.

Criminal charges were filed overnight in an American federal court against Sharp, of Portland, Oregon. The indictment valued the 50 Bitcoins at $1.9m “based on the prevailing exchange rate at the time.”

US attorney Damian Williams said in a US Justice Department statement: “As further alleged, after the FBI searched his home in connection with the theft, Sharp, now posing as an anonymous company whistle-blower, planted damaging news stories falsely claiming the theft had been by a hacker enabled by a vulnerability in the company’s computer systems.”

Sharp is alleged to have downloaded an admin key which gave him “access to other credentials within Company-1’s infrastructure” from Ubiquiti’s AWS servers at 03:16 local time on 10 December 2020, using his home internet connection. Two minutes later, that same key was used to make the AWS API call GetCallerIdentity from an IP address linked to VPN provider Surfshark – to which Sharp was a subscriber, prosecutors claimed.

Later that month, according to the prosecution, he is alleged to have set AWS logs to a one-day retention policy, effectively masking his presence.

Eleven days after the AWS naughtiness, the indictment claims, he used his own connection to log into Ubiquiti’s GitHub infrastructure. “Approximately one minute later,” alleged the indictment, Sharp used Surfshark to ssh into GitHub and clone around 155 Ubiquiti repos to his home computer.

“In one fleeting instance during the exfiltration of data,” said the indictment, “the Sharp IP address was logged making an SSH connection to use GitHub Account-1 to clone a repository.”

For the rest of that night, prosecutors said, logs showed Sharp’s personal IP alternating with a Surfshark exit node while making clone calls. Although it was not spelled out in the court filing, prosecutors appeared to be suggesting that Surfshark VPN was dropping out and revealing “the attacker’s” true IP.

Ubiquiti discovered what was happening on 28 December. Prosecutors claimed Sharp then joined the company’s internal response to the breaches.

In January 2021 Ubiquiti received a ransom note sent from a Surfshark VPN IP address demanding 25 Bitcoins. If it paid an extra 25 Bitcoins on top of that, said the note, its anonymous author would reveal a backdoor in the company’s infrastructure. This appears to be what prompted Ubiquiti to write to its customers that month alerting them to a data breach. Ubiquiti did not pay the ransom, said the indictment.

Shortly after Federal Bureau of Investigation workers raided Sharp’s home, prosecutors claim he “caused false or misleading news stories to be published about the Incident and Company-1’s disclosures and response to the Incident. Sharp identified himself as an anonymous source within Company-1 who had worked on remediating the Incident. In particular, Sharp pretended that Company-1 had been hacked by an unidentified perpetrator who maliciously acquired root administrator access [to] Company-1’s AWS accounts.”

This appears to be referencing an article by infosec blogger Brian Krebs that was published that day, on 30 March 2021. He spoke “on condition of anonymity for fear of retribution by Ubiquiti”, and El Reg (among many other outlets) followed up Krebs’ reporting in good faith. In that article, the “whistleblower” said he had reported Ubiquiti in to the EU Data Protection Supervisor, the political bloc’s in-house data protection body.

We have asked Krebs for comment.

Sharp is innocent unless proven guilty. He is formally charged with breaches of the Computer Fraud and Abuse Act, transmitting interstate threats, wire fraud and making false statements to the FBI. If found guilty on all counts and handed maximum, consecutive sentences on each, he faces 37 years in prison. ®

Source link

Continue Reading


Limerick’s Serosep crowned Irish Medtech Company of the Year 2021

Voice Of EU



Other winners at the Irish Medtech Association awards included Alcon Ireland, West, Vertigenius, Luminate Medical, BioMEC, Jabil Healthcare, Cook Medical and Aerogen.

Limerick-headquartered business Serosep has been named Irish Medtech Company of the Year at a virtual conference hosted today (2 December) by The Irish Medtech Association with Enterprise Ireland and IDA Ireland.

The Irish Medtech Association which represents the medtech sector in Ireland made the announcement at its annual Medtech Rising conference. This year’s awards ceremony was the first to feature new categories. Alcon Ireland won the Sustainable Medtech company of the Year, while West scooped the Best Medtech Talent Strategy Award.

According to the association’s director Sinéad Keogh, the annual awards ceremony offers the medtech community a chance to “recognise and celebrate the strength and importance of the industry in improving life.”

“The sector has remained resilient despite the challenges of the Covid pandemic, with over 42,000 people now working in the industry, across 450 companies,” she added.

The overall winner, Serosep, is a self-funded, family run business, which manufactures clinical diagnostic products at its base in Annacotty, Co Limerick. It serves more than 35 different countries spread over 5 continents. The company is 25 years in business and employs 114 people. Earlier this year, it announced a five-year contract to supply its gastroenteritis diagnostic system to Liverpool University Hospital. The company already supplies the NHS.

Serosep CEO and founder Dermot Scanlon, said he was “humbled” to receive the award, adding that the company’s innovative diagnostic test tools have “changed the way gastroenteritis is tested in clinical laboratories.”

“We are currently manufacturing in excess of one million tests in our state-of-the-art facility,” he said, explaining that the award would motivate the whole company to “continue forging ahead, achieving bigger and better things.”

Other award winners included:

Trinity College Dublin spin-out Vertigenius, winner of the eHealth Innovation of the Year Award. Vertigenius is a platform which aims to enhance clinical and patient engagement in the treatment of balance problems.

Luminate Medical, winners of the Emerging Medtech Company of the Year Award. The NUI Galway spin-out has developed a technology to prevent chemotherapy induced hair loss.

NUI Galway’s Biomechanics Research Centre (BioMEC) won the Academic Contribution to Medtech Award. The company’s technology integrates the latest in silico computational models to simulate the mechanical performance of implanted coronary stents.

Bray-based Jabil Healthcare scooped the Medtech Partner/Supplier of the Year Award for its new Covid-19 PCR testing device.

Cook Medical received the Women in Leadership Company initiative Award for its commitment to gender balance in the workplace.

The Covid-19 Response Recognition Award was awarded to Aerogen which has developed an inhaled vaccine station. The company’s products have been used on more than 3m critically ill people since March 2020, according to Enterprise Ireland’s head of life sciences, Deirdre Glenn. Aerogen won last year’s Medtech Company of the Year award.

Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.

Source link

Continue Reading


‘A lemon’: Coalition fights to keep Covidsafe app data under wraps | Australia news

Voice Of EU



The Morrison government insists it is negotiating with the states about “future uses” for its troubled Covidsafe app despite it not being used during the outbreaks that prompted lockdowns in Victoria, New South Wales and the Australian Capital Territory.

The government is also refusing to release how many Australians continue to use the app, with one tech expert accusing the government of trying to avoid disclosing embarrassing data rather than admit it had failed to achieve its purpose.

Since vaccination rates reached more than 90% of the eligible population in most states, contact tracing is slowly being scaled back, with health authorities limiting the number of people contacted and asked to test and isolate.

Even when contact tracing played a critical role in reducing the number of cases, the app was of little assistance.

Almost none of the contacts were identified through the federal government’s CovidSafe contact tracing app despite well over 7 million people in Australia downloading it last year and the prime minister, Scott Morrison, declaring it the ticket out of lockdown.

Since launching in April last year, just 17 “close contacts” in NSW were found directly through the app that were not otherwise identified through manual contact tracing methods.

Guardian Australia has been engaged in a year-long freedom of information battle with the Digital Transformation Agency to reveal how many people continued to use the app after installing it.

This month the agency said releasing the information would hurt negotiations with the states over the app’s future uses.

“The Commonwealth is engaged in ongoing consultations and discussions with the states and territories on a framework around the use of Covidsafe data and data derived from Covidsafe data as a key tool for contact tracing,” DTA’s chief technology officer, Anthony Warnock, told the Office of the Australian Information Commissioner in a letter provided to Guardian Australia.

When asked about these discussions, both NSW and Victoria said the app had not been used at all in 2021.

“To date, it has not been necessary to use the Covidsafe app with any case clusters in 2021,” a NSW Health spokesperson said. “NSW Health’s contact tracing team has access to a variety of information to contain the spread of Covid-19 and keep the community safe.”

The ACT also said the app had never been used in the capital and, as of September, Queensland said it had used the app twice, with one contact identified but no positive cases identified.

It’s also unclear what future uses the federal government is considering.

Electronic Frontiers Australia’s chair, Justin Warren, who has been involved in complex FOI battles with the government, suggested the only reason the the release of the information would be damaging was if it showed far fewer people continued to use the app.

“The DTA appears to be trying to argue that we can’t learn the truth about just how big a lemon the Covidsafe app is because then people might know it’s a lemon and act accordingly,” he said. “It’s clear to me that they wouldn’t try to make this argument if the app was useful.”

The app costs around $75,000 a month to run, and a spokesperson for the federal health department said there were “no plans” to shut it down until the health minister determined it was no longer required.

Experts in the tech community last year called for the app to be modified using the Apple-Google exposure notification framework, which would work similarly to the UK’s NHS app and alert people when they had been in contact with a confirmed Covid-19 case.

A study published in Nature in May about how effective the NHS app in England and Wales had been between September and December last year found that for every positive case who agreed to alert their contacts, one case was averted.

The government has long argued against switching to an NHS-style version of the app, arguing that it left it up to users to contact the health department and get tested and isolate, rather than giving contact tracers a list of those exposed to follow up.

But a ministerial brief prepared by the DTA in May 2020, released this week on the transparency website Right to Know, reveals that the government believed it would require massive changes to the app and privacy laws to accommodate the change.

“The app would need to be significantly redesigned and rebuilt,” the agency said. “The ENF cannot simply be embedded into the current app. The health portal would also need to be redesigned and rebuilt.”

The DTA warned that a new privacy assessment would need to be undertaken, legislation might need to be amended, all current users would need to download and re-register through the app, and contact data could not be transferred.

The briefing also noted that the alerts people received through the app “may cause alarm” if contact tracers were not involved in the process.

Sign up to receive an email with the top stories from Guardian Australia every morning

But the agency said a change to the Apple/Google version would improve connectivity between devices and might encourage people who had hesitated to download the original app.

“Certain users who have avoided the app may perceive that the ENF provides stronger privacy protections through this largely decentralised non-government-controlled model.”

Victoria now automatically alerts people who were at high-risk venues through the Service Victoria app, and advises them to test and isolate, but does not do any further contact tracing except when someone tests positive.

NSW is planning to ditch QR code check-ins from all but high-risk venues from 15 December, or when the state reaches 95% of the eligible population having two doses of the vaccine.

Source link

Continue Reading


Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates 
directly on your inbox.

You have Successfully Subscribed!